Brass Tax Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Brass Tax Wealth Management's PFE Position: Q3 2025 in Review
Brass Tax Wealth Management reduced its Pfizer (PFE) stake by 0.35% in Q3 2025, selling an estimated $938 and leaving 10,768 shares worth $274K. The position accounts for 0.05% of the portfolio, ranked #197.
Brass Tax Wealth Management first reported a position in PFE in Q1 2024 and has held it in 7 quarters since. The position peaked at $395K in Q3 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Brass Tax Wealth Management held 10,768 shares of Pfizer worth $274K as of Q3 2025.
- Brass Tax Wealth Management sold 38 Pfizer shares in Q3 2025, an estimated $938.
- Pfizer made up 0.05% of Brass Tax Wealth Management's portfolio in Q3 2025, its #197 holding.
- Brass Tax Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 7 quarters since.
- Brass Tax Wealth Management's Pfizer position peaked at $395K in Q3 2024.
- 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Brass Tax Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.